Treatment of Neurohypophyseal Diabetes Insipidus
The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
CONTEXT: In recent years, there have been several improvements in the treatment of neurohypophyseal diabetes insipidus (DI). They include new formulations of the vasopressin analog, desmopressin; a better understanding of the effect of fluid intake on dosing; and more information about treatments of infants, children, and pregnant women who present special challenges. This review aims to summarize past and current information relative to the safety and efficacy of treatments for the types of DI caused by a primary deficiency of vasopressin. EVIDENCE ACQUISITION: The review is based on publications identified primarily by a PubMed search of the international literature without limitations of date. EVIDENCE SYNTHESIS: In acute settings where fluid intake is determined by factors other than thirst, desmopressin should be given iv in doses that have a short duration of action and can be adjusted quickly in accordance with changes in hydration as indicated by plasma sodium. In ambulatory patients, the oral formulations (tablet or melt) are preferred for their convenience. If fluid intake is regulated normally by the thirst mechanism, the tablets or melt can be taken safely 1 to 3 times a day in doses sufficient to completely eliminate the polyuria. However, if fluid intake consistently exceeds replacement needs as evidenced by the development of hyponatremia, the dose should be reduced to allow higher than normal rates of urine output or intermittent breakthrough diuresis. This regimen is often indicated in infants or children because their rate of fluid intake tends to be greater than in adults. In all cases, the appropriate dose should be determined by titration, owing to considerable interindividual differences in bioavailability and antidiuretic effect. CONCLUSIONS: Desmopressin can provide effective and safe therapy for all patients with neurohypophyseal or gestational DI if given in doses and by a route that takes into account the determinants of fluid intake.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As GH suppresses the conversion of cortisone to cortisol, patients receiving GC replacement may require higher doses once GH is initiated, and those with low adrenal reserve may be rendered hypoadrenal by the GH therapy (183,187).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [183]
In the citing paper
“Many features of hypopituitarism, such as visceral obesity, insulin resistance, osteoporosis, and increased vascular mortality are reminiscent of Cushing's syndrome (183,184).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [183]
In the citing paper
“Lower doses of HC might be needed in women with hypopituitarism (compared with primary AI) who are not treated with GC replacement (28,110,112,183,184).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [183]
In the citing paper
“The oral desmopressin has low bioavailability but good antidiuretic effect [3]”
From Diabetes Insipidus after Traumatic Brain Injury (2015) · cites this paper as [3]
Citations
Cites
Aquaporins in the Kidney: From Molecules to Medicine
Nielsen, S., Frøkiær, J., Marples, D., Kwon, T.-H., Agre, P., & Knepper, M. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00024.2001 · Cited by 1,251 · cited 1×
“Both produce antidiuresis by stimulating V2 receptors on the principal cells of the kidney (13).”
Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus
Rosenthal, W., Seibold, A., Antaramian, A., Lonergan, M., Arthus, M.-F., Hendy, G. N., Birnbaumer, M., & Bichet, D. G. (1992) · Nature · doi:10.1038/359233a0 · Cited by 333 · cited 1×
“This type is referred to as nephrogenic DI and can also be acquired or genetic (4, 5).”
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296 · cited 1×
“Desmopressin does not have this effect because it is relatively inactive at V1 receptors (14).”
Zerbe, R. L., & Robertson, G. L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112243052601 · Cited by 268 · cited 1×
“This finding is consistent with a previous suggestion that the concentrating capacity of the human kidney decreases in the absence of vasopressin and seems to require more than 8 hours of continued stimulation to fully recover (24).”
Self-citationHyponatremia Associated with Carbamazepine and Oxcarbazepine Therapy: A Review
Van Amelsvoort, T., Bakshi, R., Devaux, C. B., & Schwabe, S. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02930.x · Cited by 250 · cited 1×
“Use of carbamazepine to treat neurological disorders has also been implicated in the development of hyponatremia with inappropriate antidiuresis (50).”
Abnormalities of thirst regulation
Robertson, G. L. (1984) · Kidney International · doi:10.1038/ki.1984.39 · Cited by 193 · cited 4×
“Dipsogenic polydipsia Tubeculous meningitis Neurosarcoidosis Head trauma Idiopathic Causes of hypodipsia and vasopressin deficiency resulting from destruction of osmoreceptors (86) Tumors Craniopharyngioma Pinealoma Meningioma Metastatic Granulomas Histiocytosis Sarcoidosis Vascular Occlusion of anterior communicating…”
InfluentialSelf-citationOsmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy
Lindheimer, M. D., & Davison, J. M. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320133 · Cited by 179
EFFECT OF A SYNTHETIC ANALOGUE OF VASOPRESSIN IN ANIMALS AND IN PATIENTS WITH DIABETES INSIPIDUS
Vávra, I., Machová, A., Holecek, V., Cort, J. H., Zaoral, M., & Sorm, F. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90904-5 · Cited by 179 · cited 1×
“the first clinical trial over 40 years ago (16).”
Familial forms of diabetes insipidus: clinical and molecular characteristics
Babey, M., Kopp, P., & Robertson, G. L. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.100 · Cited by 172 · cited 5×
“For long-term management, however, the only practical way to reduce the polyuria, thirst, and polydipsia is to reduce sodium intake and give a thiazide diuretic, amiloride, or prostaglandin synthetase inhibitors (2, 4).”
InfluentialSelf-citationDesmopressin 30 Years in Clinical Use: A Safety Review
Vande Walle, J., Stockner, M., Raes, A., & Norgaard, J. (2007) · Current Drug Safety · doi:10.2174/157488607781668891 · Cited by 172
Self-citationDiabetes Insipidus in Pregnancy Associated with Abnormally High Circulating Vasopressinase Activity
Durr, J. A., Hoggard, J. G., Hunt, J. M., & Schrier, R. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704233161707 · Cited by 168 · cited 6×
“Gestational DI is controlled much better with desmopressin than with vasopressin because the analog is resistant to degradation by the placenta (10).”
InfluentialChlorothiazid in Diabetes Insipidus
CRAWFORD, J. D., & KENNEDY, G. C. (1959) · Nature · doi:10.1038/183891a0 · Cited by 164
DDAVP in the Treatment of Central Diabetes Insipidus
Robinson, A. G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197603042941001 · Cited by 163
Antidiuretic Action of Chlorpropamide in Idiopathic Diabetes Insipidus
Arduíno, F., FERRAZ, F. P. J., & RODRIGUES, J. (1966) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-26-12-1325 · Cited by 144 · cited 1×
“This effect, which was discovered accidentally almost 50 years ago (51), occurs at doses similar to those used in diabetes mellitus (250 to 500 mg orally once a day), reaches a maximum within 3 to 10 days of starting treatment, reduces urine volume by an average of about 60% (range, 30 to 90%) in patients with severe…”
Fjellestad‐Paulsen, A., Höglund, P., Lundin, S., & Paulsen, O. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00990.x · Cited by 138 · cited 2×
“Due to degradation by gastrointestinal peptidases, its bioavailability by the oral route is low (25) (Table 2).”
Ito, M., Mori, Y., Oiso, Y., & Saito, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115052 · Cited by 135 · cited 1×
“It is variously referred to as neurohypophyseal, pituitary, cranial, or central DI and can result from various diseases or genetic mutations that impair neurohypophyseal function (3, 4) (Table 1).”
Self-citationEFFECTS OF DDAVP, A SYNTHETIC ANALOGUE OF VASOPRESSIN, IN PATIENTS WITH CRANIAL DIABETES INSIPIDUS
Andersson, K. ‐., & Arner, B. (1972) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1972.tb04772.x · Cited by 109
Moses, A. M., Numann, P., & Miller, M. (1973) · Metabolism · doi:10.1016/0026-0495(73)90029-2 · Cited by 102
Clofibrate-Induced Antidiuresis
Moses, A. M., Howanitz, J. H., van Gemert, M., & Miller, M. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107213 · Cited by 93 · cited 1×
“Clofibrate, a drug formerly used to treat certain hyperlipidemias, also has an antidiuretic effect in neurohypophyseal DI (65, 75, 76).”
Mechanism of Chlorpropamide Action in Diabetes Insipidus
Miller, M., & Moses, A. M. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-4-488 · Cited by 92
Kimura, T., Matsui, K., Sato, T., & YOSHINAGA, K. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-3-356 · Cited by 89
The Antidiuretic Action of Carbamazepine in Man
Meinders, A. E., Cejka, V., & Robertson, G. L. (1974) · Clinical Science · doi:10.1042/cs0470289 · Cited by 81 · cited 1×
“Other treatments Carbamazepine, a drug used to treat neurological disorders, also has a significant antidiuretic effect in neurohypophyseal DI (45, 46).”
Self-citationKennedy, R. M., & Earley, L. E. (1970) · New England Journal of Medicine · doi:10.1056/nejm197005212822107 · Cited by 79 · cited 1×
“The thiazide diuretics impair the ability to excrete a water load and, as a consequence, can produce severe water intoxication with dilutional hyponatremia if given inadvertently to a patient with primary polydipsia (79).”
Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine.
Stephens, W. P., Coe, J. Y., & Baylis, P. H. (1978) · BMJ · doi:10.1136/bmj.1.6125.1445 · Cited by 78 · cited 1×
“Studies employing immunoassays have shown that carbamazepine reduces plasma vasopressin in healthy subjects (47–49), although in 1 study (47) it impaired urinary dilution in response to a water load.”
Rittig, S. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00340.x · Cited by 74
Antidiuretic Effect and Complications of Chlorpropamide Therapy in Diabetes Insipidus
WEBSTER, B., & Bain, J. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-2-215 · Cited by 68 · cited 1×
“In patients who do not get satisfactory control of their DI with chlorpropamide therapy alone, the effects can be enhanced considerably by the addition of chlorothiazide (59) or carbamazepine (70).”
Rivkees, S. A., Dunbar, N., & Wilson, T. A. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.4.459 · Cited by 65 · cited 1×
“Once-daily doses may be effective in small children and infants (39).”
GOLD, P. W., ROBERTSON, G. L., BALLENGER, J. C., KAYE, W., CHEN, J., RUBINOW, D. R., GOODWIN, F. K., & POST, R. M. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-5-952 · Cited by 64
Self-citationTREATMENT OF DIABETES INSIPIDUS IN CHILDREN WITH DDAVP, A SYNTHETIC ANALOGUE OF VASOPRESSIN
Aronson, A. S., Anderson, K. ‐., BERGSTRAND, C. G., & Mulder, J. L. (1973) · Acta Paediatrica · doi:10.1111/j.1651-2227.1973.tb08080.x · Cited by 58
LAM, K. S. L., WAT, M. S., CHOI, K. L., IP, T. P., PANG, R. W. C., & KUMANA, C. R. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.39914.x · Cited by 58 · cited 1×
“Clinical studies of the pharmacokinetics, pharmacodynamics, efficacy, and safety of oral desmopressin tablets have also been conducted in Japanese and Chinese patients with neurohypophyseal DI (40, 41).”
Potentiation of the Antidiuretic Effect of Vasopressin by Chlorpropamide
Berndt, W. O., MILLER, M., Kettyle, W. M., & Valtin, H. (1970) · Endocrinology · doi:10.1210/endo-86-5-1028 · Cited by 58
Rittig, S., Jensen, A. R., Jensen, K., et al. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3401166.x · Cited by 55 · cited 1×
“However, the antidiuretic action of the drug is not affected, at least for the first 3 hours after treatment (36).”
Robertson, G. L. (1987) · PubMed · Cited by 51
Self-citationVasopressin Secretion in Primary Polydipsia and Cranial Diabetes Insipidus
Baylis, P. H., Gaskill, M. B., & Robertson, G. L. (1981) · QJM · doi:10.1093/oxfordjournals.qjmed.a067692 · Cited by 49 · cited 1×
“In this type, vasopressin is synthesized normally, but its secretion is suppressed by excessive fluid intake (11).”
Self-citationDDAVP treatment of diabetes insipidus during pregnancy and the post-partum period
Burrow, G. N., Wassenaar, W. G., Robertson, G. L., & Sehl, H. (1981) · European Journal of Endocrinology · doi:10.1530/acta.0.0970023 · Cited by 46 · cited 1×
“Desmopressin can be administered postpartum to nursing mothers because very little appears in breast milk (84).”
Self-citation1-Deamino-8-d-arginine vasopressin in the treatment of central diabetes insipidus in childhood
Becker, D. J., & Foley, T. P. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80389-8 · Cited by 44 · cited 1×
“hours for a 20- g dose (20, 30, 31) and from 4 to 18 hours”
CHLORPROPAMIDE TREATMENT IN DIABETES INSIPIDUS
Meinders, A. E., TOUBER, J. L., & Vries, L. A. D. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90502-8 · Cited by 43
Bode, H. H., Harley, B. M., & Crawford, J. D. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90265-8 · Cited by 41 · cited 1×
“In some respects the latter may be preferred because the level of control tends to be more stable and chlorpropamide may also stimulate thirst (88).”
Antidiuretic Effect of 1-Propyl-3-p-chlorobenzene-sulfonylurea (Chlorpropamide)1
Membrives, J. R., Moledo, L. I., Ae, L., & MEGÍAS, A. (1968) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-28-3-332 · Cited by 39 · cited 1×
“Chlorpropamide also impairs modestly the ability to dilute the urine after water loading not only in patients with neurohypophyseal DI (56, 64–66, 71), but also in most normal subjects (52, 53, 58, 60, 65).”
Arima, H., Oiso, Y., Juul, K. V., & Nørgaard, J. P. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0165 · Cited by 39
Self-citationFUKUDA, I., HIZUKA, N., & TAKANO, K. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.437 · Cited by 38 · cited 1×
“Clinical studies of the pharmacokinetics, pharmacodynamics, efficacy, and safety of oral desmopressin tablets have also been conducted in Japanese and Chinese patients with neurohypophyseal DI (40, 41).”
Oral desmopressin in central diabetes insipidus.
Westgren, U., Wittstrom, C., & Harris, A. S. (1986) · Archives of Disease in Childhood · doi:10.1136/adc.61.3.247 · Cited by 36 · cited 2×
“Due to the ease of administration, oral formulations are the preferred route for the treatment of most patients (35, 37).”
Central diabetes insipidus in children.
Fjellestad‐Paulsen, A., Tubiana‐Rufi, N., Harris, A. S., & Czernichow, P. (1987) · European Journal of Endocrinology · doi:10.1530/acta.0.1150307 · Cited by 36 · cited 2×
“was found to be 7 to 9 hours, respectively (33).”
Acute Diabetes Insipidus Mediated by Vasopressinase After Placental Abruption
Wallia, A., Bizhanova, A., Huang, W., Goldsmith, S. L., Gossett, D. R., & Kopp, P. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3548 · Cited by 35 · cited 1×
“However, it can also develop immediately after delivery due to massive release of vasopressin from an abruptio placenta (9).”
Fjellestad‐Paulsen, A., Tubiana‐Rufi, N., Harris, A. S., et al. (1987) · PubMed · Cited by 34
Mechanism of Chlorpropamide Antidiuresis in Diabetes Insipidus
Ettinger, B. B., & Forsham, P. H. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-31-5-552 · Cited by 32 · cited 1×
“The mechanism of the antidiuretic effect of chlorpropamide in neurohypophyseal DI probably does not involve an increase in vasopressin secretion (69), although it may have this effect in healthy adults (65).”
DDAVP in Treatment of Vasopressin-Sensitive Diabetes Insipidus
Ward, M. K., & Fraser, T. R. (1974) · BMJ · doi:10.1136/bmj.3.5923.86 · Cited by 32 · cited 1×
“after 5 to 10 g of intranasal desmopressin (32).”
CHLORPROPAMIDE TREATMENT IN DIABETES INSIPIDUS
Larsen, I. F., & Haugen, H. N. (1968) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1968.tb10498.x · Cited by 31
Home sodium monitoring in patients with diabetes insipidus
Green, R. P., & Landt, M. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.128544 · Cited by 30 · cited 1×
“Consequently, it is necessary to prescribe fluid intake on a sliding scale based on daily changes in weight and/or plasma sodium (86, 87).”
Ultralow doses of yasopressin in the management of diabetes insipidus
Chanson, P., Jedynak, C. P., Dabrowski, G., Rohan, J., Bouchama, A., de Rohan-Chabot, P., & Loirat, P. (1987) · Critical Care Medicine · doi:10.1097/00003246-198701000-00010 · Cited by 29
Fjellestad‐Paulsen, A., & Czernichow, P. (1986) · Acta Paediatrica · doi:10.1111/j.1651-2227.1986.tb10259.x · Cited by 28
Use of Subcutaneous DDAVP in Infants with Central Diabetes Insipidus
Blanco, E. J., Lane, A., Aijaz, N., Blumberg, D. A., & Wilson, T. A. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.7.919 · Cited by 28 · cited 1×
“08 g twice daily is sometimes preferred (81).”
Temporal delays and individual variation in antidiuretic response to desmopressin
Juul, K. V., Erichsen, L., & Robertson, G. L. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00502.2012 · Cited by 28 · cited 2×
“This time dependency was also observed in a recent study in water-loaded healthy adults (23).”
Self-citation5 Water metabolism and vasopressin secretion during pregnancy
Barron, W. M. (1987) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(87)80038-x · Cited by 27
Desmopressin duration of antidiuretic action in patients with central diabetes insipidus
Juul, K. V., Bichet, D. G., & Nørgaard, J. P. (2011) · Endocrine · doi:10.1007/s12020-011-9492-z · Cited by 26
Self-citationRado, J. P. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-1-1 · Cited by 22 · cited 1×
“In patients who do not get satisfactory control of their DI with chlorpropamide therapy alone, the effects can be enhanced considerably by the addition of chlorothiazide (59) or carbamazepine (70).”
Chlorpropamide effect: Measurement of neurophysin and vasopressin in humans and rats
Pokracki, F. J., ROBINSON, A. G., & SEIF, S. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90222-5 · Cited by 22
Dürr, J. A., Hensen, J., Ehnis, T., Blankenship, M. S., & Klein), (. T. T. A. O. C. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f799 · Cited by 22 · cited 1×
“Most of the clinical evidence suggests that chlorpropamide acts by potentiating the antidiuretic effect of the very low levels of plasma vasopressin that persist even in patients with severe neurohypophyseal DI (57, 58, 63–65, 72, 73), but a more recent study in LLC-PK cells indicates that chlorpropamide has a direct…”
Effect of Carbamazepine on Plasma and Urine Arginine-Vasopressin
Thomas, T. H., Ball, S. G., Wales, J. K., & Lee, M. R. (1978) · Clinical Science · doi:10.1042/cs0540419 · Cited by 20
Mechanism of Chlorpropamide Action in Patients with Diabetes Insipidus
Murase, T., & Yoshida, S. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-1-174 · Cited by 19
A Potential Danger of Oral Chlorpropamide Therapy: Impaired Excretion of a Water Load12
Linshaw, M. A., Sey, M., DiGeorge, A. M., & Gruskin, A. B. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-3-562 · Cited by 14
Chlorpropamide in idiopathic diabetes insipidus
Andreani, D., Cinotti, G. A., & Stirati, G. (1969) · Metabolism · doi:10.1016/0026-0495(69)90063-8 · Cited by 14
Clinical Value and Mode of Action of Chlorpropamide in Diabetes Insipidus
Rad�, J. P., Szende, L., ly, L. B., & Tak??, J. (1970) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197012000-00005 · Cited by 13
Comparison of clofibrate and chlorpropamide in vasopressin-responsive diabetes insipidus
Thompson, P., Earll, J. M., & Schaaf, M. (1977) · Metabolism · doi:10.1016/0026-0495(77)90062-2 · Cited by 13
The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Jp, R., Marosi, J., Szende, L., Borbély, L., Takó, J., & Fischer, J. (1976) · PubMed · Cited by 13
5 Water metabolism and vasopressin secretion during pregnancy
Lindheimer, M. D., & Barron, W. M. (1994) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80323-2 · Cited by 13
Transient Diabetes Insipidus during Pregnancy
Oiso, Y. (2003) · Internal Medicine · doi:10.2169/internalmedicine.42.459 · Cited by 12
Self-citationGreene, J. A., & JANUARY, L. E. (1940) · JAMA · doi:10.1001/jama.1940.02810400035007 · Cited by 12 · cited 1×
“for long-term management of neurohypophyseal DI (27)”
Zerbe, R. L., & Robertson, G. L. (1982) · The Journal of Urology · doi:10.1016/s0022-5347(17)52853-0 · Cited by 12
Self-citationEvidence for a Role of Antidiuretic Hormone (ADH) in the Antidiuretic Action of Chlorpropamide
Liberman, B., Borges, R., & WAJCHENBERG, B. L. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-5-894 · Cited by 11
Treatment of diabetes insipidus.
Andersson, K., & ARNER, B. (1971) · BMJ · doi:10.1136/bmj.3.5766.111-a · Cited by 9
Jp, R., Marosi, J., Fischer, J., Takó, J., & Kiss, N. (1975) · PubMed · Cited by 9
Antidiuretic effect of chlorpropamide.
Meinders, A. E., van Leeuwen, A. M., & Vries, L. A. D. (1969) · PubMed · Cited by 7
Jp, R., Marosi, J., Borbély, L., & Takó, J. (1976) · PubMed · Cited by 7
Mechanism of Chlorpropamide Action in Diabetes Insipidus.
Miller, M., & Moses, A. M. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-5-789_4 · Cited by 6 · cited 1×
“Chlorpropamide also impairs modestly the ability to dilute the urine after water loading not only in patients with neurohypophyseal DI (56, 64–66, 71), but also in most normal subjects (52, 53, 58, 60, 65).”
Jp, R., Marosi, J., & Fischer, J. (1976) · PubMed · Cited by 6
Chlorpropamide in diabetes insipidus
Aloia, J. F., FIGLIA, M. D., CAPELLI, J., SIMENHOFF, M., & FIELD, R. A. (1972) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197209000-00008 · Cited by 6
Green, R. P., Majzoub, J. A., & Muglia, L. J. (2005) · Clinical Pediatric Endocrinology · doi:10.1002/9780470987117.ch17 · Cited by 4
Treatment of Diabetes Insipidus in Adults
Drincic, A., & Robertson, G. L. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-700-0_2 · Cited by 4 · cited 3×
“In this type, treatment with vasopressin or an analog such as desmopressin completely eliminates the polyuria, thirst, and polydipsia (2).”
Self-citationGENNES, J. L. D., Bertrand, C., Bigorie, B., & Truffert, J. (1969) · PubMed · Cited by 4
Treatment of Diabetes Insipidus
Deepika, V., Harsha, L., & Ravishankar, A. (2015) · Research Journal of Pharmacy and Technology · doi:10.5958/0974-360x.2015.00123.7 · Cited by 3
Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó, L., Mezei, G., & László, F. A. (1975) · PubMed · Cited by 3
Gutmark‐Little, I., Repaske, D., & Backeljauw, P. F. (2010) · The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego · doi:10.1210/endo-meetings.2010.part3.p7.p3-324 · Cited by 3
Hadden, D. R., Bhatia, S. K., & Montgomery, D. A. D. (1972) · Hormone Research in Paediatrics · doi:10.1159/000178259 · Cited by 2 · cited 1×
“Chlorpropamide also impairs modestly the ability to dilute the urine after water loading not only in patients with neurohypophyseal DI (56, 64–66, 71), but also in most normal subjects (52, 53, 58, 60, 65).”
Treatment of Diabetes Insipidus in Adults
Drincic, A., & Robertson, G. L. (2003) · Humana Press eBooks · doi:10.1385/1-59259-375-5:21 · Cited by 1
Self-citationChlorpropamide in diabetes insipidus
ALOIA, J. F., FIGLIA, M. D., CAPELLI, J., et al. (1972) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197226430-00008 · Cited by 1
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Christ-Crain, M., Bichet, D. G., Fenske, W. K., Goldman, M. B., Rittig, S., Verbalis, J. G., & Verkman, A. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0103-2 · Cited by 256
Diagnosis and Management of Central Diabetes Insipidus in Adults
Tomkins, M., Lawless, S., Martin-Grace, J., Sherlock, M., & Thompson, C. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac381 · Cited by 159
Diabetes insipidus: Differential diagnosis and management
Robertson, G. L. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.02.007 · Cited by 134
Self-citationDiabetes Insipidus after Traumatic Brain Injury
Capatina, C., Paluzzi, A., Mitchell, R., & Karavitaki, N. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4071448 · Cited by 120
Metadata
- Authors
- Oiso, Y., Robertson, G. L., Nørgaard, J. P., & Juul, K. V.
- Affiliations
- Ghent University (BE)
- Northwestern University (US)
- Ferring Pharmaceuticals (Denmark) (DK)
- Corresponding author
- Juul, Kristian Vinter
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-10
- Volume
- 98
- Issue
- 10
- Pages
- 3958-3967
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2154417986
- Cited by
- 101
- References
- 84
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 9 · 2019: 12 · 2018: 6 · 2017: 10 · 2016: 7 · 2015: 7 · 2014: 13 · 2013: 1
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Universiteit Gent
- Faculty of Medicine and Health, University of Sydney
- Topics
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- desmopressin, vasopressin analogue, fluid intake, hyponatremia, polyuria, dose titration, infants, children, pregnancy, gestational diabetes insipidus, plasma sodium
- MeSH terms
- Deamino Arginine Vasopressin, Humans, Polyuria, Treatment Outcome, Diabetes Insipidus, Neurogenic, Antidiuretic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.